Jazz Pharmaceuticals, Inc. (JAZZ) Misses Q3 EPS by 3c; Guides Slightly Below the Street
Tweet Send to a Friend
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q3 EPS of $1.29, $0.03 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
